The role of MRI in the surgical selection of cerebral metastases.
BACKGROUND
About one third of patients operated on for a "single" cerebral metastasis diagnosed by CT scan have probably more than one lesion. In fact, Gd-DTPA enhanced MRI has proved to be more sensitive than CT in detecting the number of cerebral metastases, reducing the number of patients candidate to surgery.


METHODS
Thirty-five patients with a CT scan picture of a single cerebral neoplasm of presumable metastatic nature performed a Gd-DTPA enhanced cerebral MRI. In 25 cases MR images confirmed a single lesion, while in other 10 (28.6%) showed a number of metastases ranging from 2 to 6. In order to assess the utility of MRI in surgical selection of patients and then to reconsider the concept of operability limited to single brain metastases only, we compared the survival of the 25 cases who preoperatively performed MRI (MRI group) with that of other 25 consecutive patients operated on in pre-MR era (during a 24-month period), with a CT picture of single cerebral metastasis (non-MRI group).


RESULTS
The median survival was 36 +/- 5 weeks for MRI group and 40 +/- 15 for non-MRI group. The Kaplan-Meier product-limit survival analysis and the log-rank test do not reveal any statistically significative difference of survival between the two groups.


CONCLUSIONS
Even if the number of patients is limited for definitive considerations, our preliminary results seem to suggest that the further selection of surgical cases obtained with MRI could not impact significatively the survival. Therefore, in selected patients with multiple cerebral metastases a surgical treatment could be reasonable.
Mastronardi
L
L
Sandro Pertini Hospital, Division of Neurosurgery, Rome, Italy. mastro@tin.it
Lunardi
P
P
Puzzilli
F
F
Schettini
G
G
Lo Bianco
F
F
Ruggeri
A
A
D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000556:secondary* / Q000601:surgery; D003287:Contrast Media; D005260:Female; D005500:Follow-Up Studies; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012680:Sensitivity and Specificity; D015996:Survival Rate; D014057:Tomography, X-Ray Computed
D003287:Contrast Media; D019786:Gadolinium DTPA